| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 5 Jul 2024 | 29 Jun 2024 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/07/2024 inter alia to consider and approve 1) To consider and approve the Directors Report and Secretarial Audit Report along with annexure for the F.Y. 2023-24; 2) To approve appointment of M/s. Rahul Doshi & Co Chartered Accountants as Internal Auditor of the Company for the Financial Year 2024-25; 3) To approve appointment of Mr. Chintan K. Patel Practicing Company Secretary as a Secretarial Auditor of the Company for F.Y. 2023-24; 4) To take noting of Resignation of Girish Bhatt as Non-Executive Director; 5) To revise and increase the limit of Borrowing power pursuant to Section 180 (1) (c ) of the Companies Act 2013; 6) To Convene the 42nd AGM of the Members of the Company and approve the draft notice of 42nd Annual General Meeting (AGM) of the Company; 7) To consider and fix the Book Closure date for the purpose of 42nd AGM of the Company; 8) To appoint Mr. Chintan K. Patel Practicing Company Secretary (Mem No: A31987 COP: 11959) as Scrutinizer to ascertain voting process of 42nd AGM; Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Friday, 5th day of July, 2024 has discussed agendas as described in Outcome. (As per BSE Announcement Dated on 05/07/2024) | ||
| Board Meeting | 30 Apr 2024 | 19 Apr 2024 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve (i) Audited results for the quarter and year ended on March 31st 2024. (ii) Appointment of Independent Director Results for Quarter & financial year ended on 31st March, 2024 Board Meeting held today for consideration and taken on record the following; 1. Audited standalone and consolidated financial results for quarter and year ended 31.03.2024 2. Resignation of Ms. Apeksha Vyas as Independent Director 3.Appointment of Ms. Rina Kumari as Independent Director 4.Resignation of Mr. Sunil Shah as Independent Director 5. Appointment of Mr. Aagam Shah as Independent Director (As per BSE Announcement Dated on 30/04/2024) | ||
| Board Meeting | 6 Feb 2024 | 30 Jan 2024 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve UNAUDITED FINANCIAL RESULTS FOR QUARTER AND NINE MONTHS ENDED DECEMBER31ST 2023 OUTCOME OF THE BOARD MEETING FOR UNAUDITED FINANCIAL RESULTS FOR QUARTER AND NINE MONTHD ENDED 31ST DECEMBER,2023 (As Per BSE Announcement Dated on: 06/02/2024) | ||
| Board Meeting | 26 Oct 2023 | 11 Oct 2023 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2023 inter alia to consider and approve The Un-audited financial results for quarter ended 30th September 2023. Any other business with the permission of Chair In continuation of our letter Dated October 11, 2023 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Thursday, October 26, 2023 at Registered Office of the Company has inter alia considered and approved the Un-audited Financial Results along with Limited Review Report of the Company for the Quarter and Half- Year ended on 30th September, 2023; The Board of Directors of the Company at its meeting held today i.e. 26th October, 2023 at Registered office of the Company has inter alia considered & approved the Un-audited Financial Results along with Limited Review Report of the Company for the Quarter & Half year ended on 30th September, 2023. (As Per BSE Announcement Dated on 26.10.2023) | ||
| Board Meeting | 10 Aug 2023 | 3 Aug 2023 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Un-audited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2023. Board at its meeting held today i.e.: 10.08.2023 has upon review by audit committee has considered and approved the unaudited standalone and consolidate financial results for the quarter ended June 30, 2023. (As Per BSE Announcement dated on 10.08.2023) Revised Outcome of the Board Meeting for Quarter ended June 30, 2023. (As Per BSE Announcement Dated on 01/09/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
